Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers

Thrombosis and Haemostasis

Volumn 77, Issue 6, 1997, Pages 1077-1080

  Blann, Andrew D ^a   Lip, Gregory Y H ^a   Beevers, D Gareth ^b   McCollum, Charles N ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; CELL MARKER; ELASTASE; PADGEM PROTEIN; THROMBIN; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN SECRETION; SOLUBILITY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0030749941     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656115     Document Type: Article

References (29)

1. Borsum T. Biochemical properties of vascular endothelial cells. Virchows Archiv B Cell Pathol 1991 ; 60: 279-86.
2. Pober JS. Cytokine activation of vascular endothelium: physiology and pathology. Am J Pathol 1988; 113: 426-33.
3. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993; 11: 767-804.
4. Blann AD, McCollum CN. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994: 8: 10-5.
5. Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A. Boisseau M. Plasma thrombomodulin: new approach of endothelium damage. Int Angiology 1993; 12: 355-9.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
7. Cahill MR, Newland AC. Platelet activation in coronary artery disease. Br J Biomed Sci 1993; 50: 221-34.
8. Rak K, Beck P, Udvardy M, Pfliegler G, Misz M, Boda Z. Plasma levels of beta thromboglobulin and factor VIII-related antigen in diabetic children and adults. Thromb Res 1983; 29: 155-62.
9. Wagner DD. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70: 105-10.
10. Niewiarowski S. Secreted platelet proteins. In 'Haemostasis and Thrombosis', 3rd edition. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds). Edinburgh: Churchill Livingstone 1994; 167-81.
11. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Valeri CR. Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Thromb Haemost 1995; 73: 1000 (abstract).
12. Jilma B, Fasching P, Ruthner C, Rumplmayr A, Ruzicka S, Kapiotis S, Wagner OF, Eichler HG, Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996; 76: 328-332.
13. Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74: 626-30.
14. Lip GYH, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertension 1995; 13: 1674-8.
15. Blann AD, Lip GYH. Hypothesis: Is soluble P-selectin a new marker of platelet activation. Atherosclerosis 1997; 128: 135-8.
16. Booth F, Allington MJ, Cederholm-Williams SA. An in vitro model for the study of acute release of von Willebrand factor from human endothelial cells. Br J Haem 1987; 67: 71-8.
17. Chignard M, Balloy V, Renesto P. Leukocyte elastase-mediated release of von Willebrand factor from cultured endothelial cells. Eur Respir J 1993; 6: 791-6.
18. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-64.
19. Altman DG. Practical statistics for medical research. London: Chapman and Hall 1991.
20. Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993; 71: 423-31.
21. Giddings JC, Shall L. Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1. Thromb Res 1987; 47: 259-67.
22. Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD. von Willebrand factor is an acute phase reactant in man. Thromb Res 1989; 53: 387-94.
23. Jilma B, Hildebrandt J, Kapiotis S, Wagner OF, Kitzweger E, Mullner C, Monitzer B, Krejcy, Eichler HG. Effects of estradiol on circulating P-selectin. J Clin Endocrinol Metab 1996; 81: 2350-5.
24. Blann AD, Seigneur M, Adams R, McCollum CN. Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur J Vasc Endovasc Surg 1996; 12: 218-22.
25. Gando S, Nakanishi Y, Kameue T, Nanzaki S. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase. J Trauma 1995; 39: 660-4.
26. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83: 1535-41.
27. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986; 78: 130-7.
28. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1986; 101: 880-6.
29. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Watanabe K, Ikeda Y. Soluble P-selectin is present in normal circulation and its plasma levels is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haem 1993; 84: 702-10.